These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 14367147)

  • 1. Essential elimination of sodium cycloheptenylethylbarbiturate (medomin) in rabbits.
    KOPPANYI T; MORGAN CF; PRINCIOTTO JV
    J Am Pharm Assoc Am Pharm Assoc; 1955 Apr; 44(4):221-3. PubMed ID: 14367147
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical study of cycloheptenylethylbarbiturate (medomin) for insomnia.
    BRUSCA DD
    J Nerv Ment Dis; 1955 Jan; 121(1):67-71. PubMed ID: 14368316
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of lipid solubility and dose on the elimination of barbiturates in rabbits.
    Kaneniwa N; Hiura M; Nakagawa S
    Chem Pharm Bull (Tokyo); 1979 Jul; 27(7):1501-9. PubMed ID: 540344
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metabolism of 5-(4-oxo-delta3-cyclohexenyl)-5-allylbarbituric acid in rabbits (author's transl)].
    Nakashima K
    Yakugaku Zasshi; 1978 Jan; 98(1):133-6. PubMed ID: 641696
    [No Abstract]   [Full Text] [Related]  

  • 5. Certain aspects of phenobarbital and barbital metabolism.
    Timar M
    Farmaco Prat; 1965 Dec; 20(12):575-80. PubMed ID: 5883897
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of drugs. XVII. Metabolic fate of methylhexabital (5-cyclohexenyl-3,5-dimethylbarbituric acid). 7. Separation and identification of biotransformation products of methylhexabital in the urine of rabbits by paper chromatography.
    TSUKAMOTO H; YOSHIMURA H; TOKI S
    Chem Pharm Bull (Tokyo); 1958 Feb; 6(1):15-8. PubMed ID: 13537142
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism of 1,3-dicyclohexyl-5,5-diallylbarbituric acid in rabbits.
    Chyczewski T
    Pol J Pharmacol Pharm; 1973; 25(4):379-84. PubMed ID: 4774246
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of drugs. XVIII. The metabolic fate of methylhexabital (5-cyclohexenyl-3,5 dimethylbarbituric acid). 8. The quantitative determination of main biotransformation products of methylhexabital in the urine of rabbits by ultra-violet spectrophotometry.
    TSUKAMOTO H; YOSHIMURA H; TOKI S
    Chem Pharm Bull (Tokyo); 1958 Feb; 6(1):88-91. PubMed ID: 13537158
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of drugs. XVI. The metabolic fate of methylhexabital (5-cyclohexenyl-3,5-dimethylbarbituric acid). 6. Studies on the reduction of 3-keto-MHB (5-(3-oxo-1-cyclohexenyl)-3,5-dimethylbarbituric acid) and on pharmacological activity of the biotransformation products of methylhexabital from the urine of rabbits.
    YOSHIMURA H
    Chem Pharm Bull (Tokyo); 1958 Feb; 6(1):13-5. PubMed ID: 13537141
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of high sugar consumption by mice on the duration of action of barbiturates and in vitro metabolism of barbiturates, aniline and p-nitroanisole.
    Strother A; Throckmorton JK; Herzer C
    J Pharmacol Exp Ther; 1971 Dec; 179(3):490-8. PubMed ID: 5136267
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro metabolism of barbiturates.
    SHIDEMAN FF
    Fed Proc; 1952 Jun; 11(2):640-6. PubMed ID: 14945528
    [No Abstract]   [Full Text] [Related]  

  • 12. [Barbiturates. III. Metabolism of veronal].
    GOLDSCHMIDT S; WEHR R
    Hoppe Seylers Z Physiol Chem; 1957 May; 308(1):9-19. PubMed ID: 13448662
    [No Abstract]   [Full Text] [Related]  

  • 13. [Metabolism of radioactive labelled barbiturates and thiobarbiturates. I. Excretion of radioactivity].
    BLOCK W; EBIGT I
    Arzneimittelforschung; 1957 Sep; 7(9):572-6. PubMed ID: 13471406
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical trial of heptabarbitone (Medomin).
    TWEEDY PS
    Gerontol Clin (Basel); 1962; 4():276-80. PubMed ID: 13994997
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolism of 5-vinyl-5-(1'-methylbutyl)-barbituric acid (Vinylbital) in human. 2. Course of metabolite elimination of racemic vinylbital in urine].
    Geldmacher-von Mallinck ; Egger B; Fröhlich F
    Arzneimittelforschung; 1971 Jul; 21(7):939-41. PubMed ID: 5109505
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of the absorption, distribution and elimination of some intravenous anesthetics by labelling them with 113m In].
    Atanasov A; Kolarova T; Popova M
    Khirurgiia (Sofiia); 1975; 28(2):165-70. PubMed ID: 1223421
    [No Abstract]   [Full Text] [Related]  

  • 17. [Distribution of a barbiturate in the rabbit].
    Iffland R
    Beitr Gerichtl Med; 1970; 27():205-8. PubMed ID: 5526671
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of the barbiturates.
    Mark LC
    Ann R Coll Surg Engl; 1971 Feb; 48(2):77-8. PubMed ID: 5551189
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative studies on the metabolism of intravenous short-acting narcotics].
    FREY HH
    Arch Int Pharmacodyn Ther; 1959 Jan; 118(1-2):12-61. PubMed ID: 13618044
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolated rat hepatocytes and 9000 g rat liver supernatant as metabolic systems for the study of the pharmacokinetics of barbiturates.
    Yih TD; van Rossum JM
    Xenobiotica; 1977 Sep; 7(9):573-82. PubMed ID: 602254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.